 |
|
|
| |
Higher Number of Concurrent Metabolic Co-Morbidities Is Associated with Increasingly Higher Risk of Significant Hepatic Fibrosis and Cirrhosis in Nonalcoholic Fatty Liver Disease Patients
|
| |
| |
Metabolic abnormalities in this study were lipids (HDL, triglycerides, glucose/HGA1C. plus ALT.
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Robert J. Wong, M.D., M.S., Tram T. Tran, M.D.,
Harvey Kaufman, M.D., Justin Niles, M.A., Robert Gish, M.D.
Division of Gastroenterology and Hepatology, Alameda Health System -
Highland Hospital, Oakland, CA;
Gilead Sciences, Foster City, CA;
Quest Diagnostics, Secaucus, NJ;
Hepatitis B Foundation
|
| |
|
|
|
|
|
